Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This test measures the ratio of 3-hydroxyisovalerylcarnitine (often called C5-OH) to octanoylcarnitine (C8) in your blood. It is part of an acylcarnitine profile performed by tandem mass spectrometry, a method that looks at many small molecules involved in energy metabolism.
The ratio helps evaluate how your body breaks down the amino acid leucine and can point to problems in biotin-dependent carboxylase enzymes. It is particularly used as a marker for 3-methylcrotonyl-CoA carboxylase (3MCC) deficiency and related conditions. Doctors use it in newborn screening follow-up and in children or adults when certain metabolic symptoms are present.
A higher-than-expected C5-OH to C8 ratio can suggest a disorder such as 3MCC deficiency or multiple carboxylase deficiency, conditions that affect how the body processes specific nutrients for energy. Finding these disorders early can guide effective steps such as targeted nutrition, carnitine support, or biotin therapy when appropriate, which can reduce episodes of metabolic stress and protect long-term health.
Your clinician may order this test after an abnormal newborn screen, to investigate unexplained vomiting, lethargy, feeding difficulties, low energy, or metabolic acidosis, or to monitor an established metabolic condition. The result also helps distinguish inherited conditions from temporary changes related to diet, intercurrent illness, or maternal factors in newborns.
Your result is interpreted together with the full acylcarnitine profile, urine organic acids, biotin status, and your symptoms. A result within the expected range is generally reassuring, although your clinician may still follow up if you have ongoing concerns or other tests suggest a metabolic issue.
If the ratio is higher than expected, your care team may repeat the test, assess vitamin use, and consider enzyme studies or genetic testing of MCCC1 and MCCC2. For newborns, maternal testing may also be recommended. Some changes are temporary, especially during illness or when taking certain supplements, so do not start or stop vitamins or medications without medical advice.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Fever, infection, or prolonged fasting can increase catabolic stress and shift acylcarnitine patterns, potentially raising the C5-OH to C8 ratio temporarily.
High-dose biotin supplements or biotin deficiency can alter carboxylase activity and affect the ratio. Tell your clinician about all vitamins and timing of your last dose.
Drugs such as valproate or certain anticonvulsants, and carnitine therapy, can change acylcarnitine profiles. Provide a complete medication list before testing.
Whether the sample is a dried blood spot or plasma, the time since last feed, and transport or storage conditions can influence results and their interpretation.
In infants, maternal metabolic status, vitamin use, or an unrecognized maternal 3MCC trait can affect the newborn’s ratio, prompting evaluation of the mother as needed.
Impaired renal or hepatic function can change acylcarnitine clearance and metabolism, which may subtly shift this ratio and related markers.
References